Kevin White
About Kevin White
Kevin White is the Global Executive Director at Bristol-Myers Squibb, with a background in biotechnology and extensive experience in management and finance.
Company
Kevin White is currently serving as the Global Executive Director at Bristol-Myers Squibb, a prominent biopharmaceutical company headquartered in New Jersey, United States. He has been with the company for over a decade, commencing his tenure in March 2010. In his role, Kevin oversees global strategies and operations, contributing significantly to the company’s ongoing success in the pharmaceutical industry.
Title
Kevin White holds the position of Global Executive Director at Bristol-Myers Squibb. In this capacity, he is responsible for leading global initiatives and strategies that drive the company’s growth and innovation in the biopharmaceutical sector.
Previous Experience at Biogen
Prior to his current role, Kevin White worked at Biogen as a Management Consultant from 2009 to 2011 in Cambridge, Massachusetts, United States. During his tenure, he gained valuable experience in the biotechnology industry, which later informed his strategies at Bristol-Myers Squibb. Additionally, he served as Vice President at Biogen Idec International from 2002 to 2008, focusing on the company's international operations and playing a key role in expanding its global footprint.
Education and Expertise
Kevin White has an extensive educational background from Lehigh University. He earned a Bachelor of Science degree with a dual focus in Accounting and Finance from Lehigh University College of Business. Furthering his education, he also obtained a Master of Business Administration (MBA) from the same institution. His academic foundation has equipped him with a strong understanding of financial management and business strategies, which he leverages in his professional roles.
Background
Kevin White's professional journey spans over two decades, marked by significant roles in the biopharmaceutical industry. His trajectory includes key positions at prominent companies such as Biogen, where he contributed to both consultancy and international operations. His current role at Bristol-Myers Squibb as the Global Executive Director sees him leveraging his extensive industry experience to drive global strategies and initiatives.